IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity

in CHF 1 000

 

Share capital

 

Treasury shares

 

Retained earnings

 

Total

Balances at January 1, 2021

 

11 080

 

(8 241)

 

3 884 708

 

3 887 547

Dividend

 

 

 

(199 440)

 

(199 440)

Trade with treasury shares (incl. change in balance)

 

 

8 241

 

1 157

 

9 398

Total comprehensive income for the period

 

 

 

349 495

 

349 495

Balances at June 30, 2021

 

11 080

 

 

4 035 920

 

4 047 000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2022

 

11 080

 

(9 205)

 

3 281 618

 

3 283 493

Dividend

 

 

 

(212 242)

 

(212 242)

Trade with treasury shares (incl. change in balance)

 

 

(18 484)

 

 

(18 484)

Total comprehensive income for the period

 

 

 

(532 926)

 

(532 926)

Balances at June 30, 2022

 

11 080

 

(27 689)

 

2 536 449

 

2 519 840

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer